Monday, December 15, 2025
Home Blog Page 704

You Can Lose Weight By Having Sex And Here’s How

Having sex isn’t such a great workout on its own, assuming you’re like most people who report only burning 100 calories at best. But did you know that, thanks to hormones, your appetite is suppressed after you do “it”? Here’s how to lose weight by having sex.

https://giphy.com/gifs/sexy-wqKYPX3oUUrn2

According to Medical News Today, men participating in a study burned on average 101 calories and women 69 calories when they had sex. The average intensity was higher than walking but lower than jogging.

At the lower end, men burned 13 calories and women 11.6, while at the top of the range, men shifted 306 calories and women 164.

While the average duration of foreplay, intercourse, and orgasm was 24.7 minutes, the actual time the couples spent having sex ranged from 12.5 to 36.9 minutes.

The data doesn’t explain how vigorous (or quick) the sex was, but it doesn’t take a doctor to conclude that if you want to lose weight by having sex, you’ll need to approach it like an Olympic athlete. Either go for the gold or don’t go at all.

https://giphy.com/gifs/MjcUR7bHAVHgs

But the “love hormone” known as oxytocin, which is produced in the hypothalamus and our gastrointestinal tract, skyrockets when we orgasm. But also, according to Dr. Elizabeth A. Lawson of the Neuroendocrine Unit at Massachusetts General Hospital in Boston :

…experiments in rodents, nonhuman primates and humans consistently show that oxytocin reduces caloric consumption.

The bad news here is that oxytocin doesn’t stay in your systems long after sex, which means you’ll only experience less than 10 minutes of a sex haze appetite.

The moral of this story is that if you want to lose weight by having sex, have more of it and make it intense. That way, you’ll reap the benefits of both the cardio and the lagging appetite. It’s basic math. Bon appetite!

https://giphy.com/gifs/mylabbox-bill-nye-science-guy-36EYJaR1Encg8

Topical CBD: The FDA Stance On Hemp Derived CBD In Cosmetics

In the last few weeks, two major drugstores publicly announced that they will start carrying products containing hemp-derived cannabidiol (“Hemp-CBD”). Both CVS and Walgreens announced that CBD topicals would be available in their stores, in a select number of states. Notably, both drug store chains limited products to non-ingestible topicals.

Dr. Scott Gottleib, the outgoing head of the FDA must have heard the news because on April 2 the FDA issued new guidelines on Hemp-CBD, updated its marijuana and hemp FAQs online, and sent a new round of warning letters to distributors of CBD products. Gottleib himself took to Twitter to chime in:

https://twitter.com/SGottliebFDA/status/1113130081210302465

The FDA has long held that Hemp-CBD cannot be added to food or dietary supplements because of the Drug Exclusion Rule. The FDA’s position is that the Food, Drug and Cosmetics Act (“FDCA”) and underlying FDA regulation do not allow articles approved as drugs to be used in food or dietary supplements unless they were marketed as such prior to public investigations into that drug. CBD has been investigated and approved of as a drug (Epidiolex) and that is the basis for the FDA’s determination. The FDA has also focused on prohibiting companies from making any type of health claims about Hemp-CBD as such claims cause the FDA to classify that product as a drug.

RELATED: Going Postal: USPS Provides Guidance On Mailing Hemp-CBD

Prior to the April 2 guidance, the FDA had side-stepped the issue of Hemp-CBD in cosmetics, unless those products were deemed drugs based on the way they were marketed (e.g., “this CBD cream cures cancer”). That is no longer the case as the FDA has updated its cannabis FAQs to include this question: What is FDA’s position on cannabis and cannabis-derived ingredients in cosmetics? 

fda cbd topicals

Before looking closely at FDA’s answer there, it’s important to understand how the FDA defines cosmetics. Cosmetics are “articles intended to be rubbed poured, sprinkled or sprayed on . . . or otherwise applied to the human body . . . for cleansing, beautifying, promoting attractiveness, or altering appearance,” except for soap which is classified separately. 21 USC 321(i). Unlike food and drugs, cosmetics and ingredients in cosmetics are not subject to pre-market approval. For cosmetics, the FDA relies on consumer complaints to monitor the industry. There has been a push for years for Congress to change laws to give the FDA broader jurisdiction over cosmetics. That hasn’t happened yet.

Though cosmetics aren’t regulated as tightly as other products, the FDA still has regulatory authority over them and their ingredients. For example, color additives used in cosmetics are generally subject to premarket approval. Additionally, the presence of a harmful ingredient in a cosmetic causes the FDA to deem that cosmetic adulterated. The FDA has determined by regulation that some ingredients cannot be used in cosmetics. For example, if a product contains chloroform (other than in trace amounts) it is deemed adulterated. According to the FDA’s FAQs, CBD does not fall into this category:

Certain cosmetic ingredients are prohibited or restricted by regulation, but currently that is not the case for any cannabis or cannabis-derived ingredients.

The story doesn’t end there though. In addition to ingredients that are prohibited by rule, cosmetics are adulterated if they contain “any poisonous or deleterious substance” which could harm users. The FDA’s FAQs take a look at this as it applies to cannabis:

Ingredients not specifically addressed by regulation must nonetheless comply with all applicable requirements, and no ingredient – including a cannabis or cannabis-derived ingredient – can be used in a cosmetic if it causes the product to be adulterated or misbranded in any way.

In other words, just because an ingredient is not prohibited per se doesn’t mean it’s safe for its intended use.

RELATED: FDA Issues More Guidance On CBD Products

Let’s also take a look at what makes a cosmetic “misbranded.” The FDA will deem a cosmetic misbranded if it is labeled in a false or misleading way, does not bear required labeling information, or is made or filled in a deceptive manner. This is true for all cosmetics, including those containing Hemp-CBD.

The bottom line is that all of these cosmetic regulations were in place before April 2. Companies selling Hemp-CBD cosmetics should have been aware of the regulatory environment before entering the industry. Are the FDA’s recent comments significant? Of course! It is important to carefully track whatever the FDA says and does with regards to Hemp-CBD. But it’s also important not to overreact. The FDA has not determined that the presence of Hemp-CBD makes a cosmetic adulterated or misbranded. That may change in the future, but I for one don’t think it will. The CBD-infused toothpaste is out of the tube and the FDA knows it.

Daniel Shortt is an attorney at Harris Bricken and this article was originally published on the Canna Law Blog

Florida & DeSantis Bungling Medical Marijuana Program Again

You’d think the Sunshine State would’ve learned its lesson by now. But Florida legislators find themselves amidst another battle with marijuana advocates over tinkering with the delivery methods over medical marijuana. This week the House pushed a bill that would place a THC cap on smokable marijuana for patients, which led to “fiery exchanges with veterans and patient advocates who accused a legislative leader of relying on faulty research,” according the South Florida Sun-Sentinel. So Florida and Governor DeSantis are bungling their medical marijuana program again.

Republicans were in favor of the bill while Democrats opposed it, reports Marijuana Business Daily. Despite the pushback from Dems, advocates, and veterans alike, the House Appropriations Committee approved the measure nonetheless. As a result, it’s headed to the House floor for a vote.

RELATED: THC Benefits That Have Nothing To Do With Getting High

The plan revolving around a THC cap comes on the heels of legislators lifting the ban of smokable marijuana for medical patients less than a month ago. That ban resulted in a years-long controversy for the state, which included multiple losses in state courts, and only ended thanks to newly-elected Republican Gov. Ron DeSantis demanding legislators do so.

But it appears history will repeat itself in the Sunshine State, as politicians hold the line on misinformed agendas. Rep. Ray Rodrigues invited what is sure to be a new controversy for the state government after basing the new bill (HB 7117) on research that claimed cannabis with less than 10 percent THC still helped patients and other studies that suggested higher levels of THC would induce psychosis in patients.

“There’s absolutely science that shows the product of medical cannabis that’s 10 percent or less of THC is helpful for medical conditions. I’m a believer. I was an agnostic on that when we passed the constitutional amendment. I’ve studied the science, and I’ve been led to believe that absolutely there’s a benefit from that,” Rodrigues said prior to the committee vote.

However, the Sun Sentinel reports that “scientists who work for one of the state’s licensed medical marijuana operators dispute the findings in the research cited by Rodrigues.” For example, the study revolving around cannabis inducing psychosis didn’t hold as much scientific weight as mainstream media headlines might’ve claimed, which we’ve previously explained here.

RELATED: Use Cannabis To Forget Fears And Overcome PTSD

Such a THC cap could further drive illicit black-market sales, opponents of the measure also argued. While the bill would provide free medical marijuana cards for veterans in an attempt to sweeten the deal, Jimmy Johnston, a veteran and president of the North Florida chapter of Weed for Warriors Project, argued it’s a carrot being dangled that would only save vets $75 a year.

“A bill that was supposed to be about helping a community that is plagued with drug addiction and drug overdose … a bill that was supposed to be about helping a veteran community that is plagued (with) suicide is now being used as leverage by lawmakers to try and impose their will on the people,” Johnston said.

All Disney World Restrooms Have This Odd Thing In Common

Mirrors have played an integral part in Disney movies: “Snow White”, “Little Mermaid”, “Beauty and the Beast” and “Alice in Wonderland”, to name just a few. Which is why it’s odd that mirrors don’t exist in Disney World bathrooms.

https://giphy.com/gifs/funny-magic-mirror-8L5VfOn2lEQUg

There are several theories as to why this is.

One, it’s expensive to install big mirrors in the theme park’s massive amount of restrooms. Two, nobody wants their vacation ruined by seeing how sweaty and windblown they look after getting off a ride.

As this article so bluntly puts it, “They say people who don’t keep full length mirrors in their house are happier. I guess Disney takes this a step further and takes away all the mirrors so you are blissfully unaware that you look like a troll. I forgot I was fat for a whole week!”

Three, no mirrors equal quicker moving lines. And four, vandalism, which is an issue at all theme parks.

RELATED: Here’s Why There Are No Mosquitos At Disney World

As this former theme park employee explains: “The mirrors in the restrooms at Universal Orlando were massive, covering most of the wall over the sinks. It costs thousands of dollars just for the mirror, not including the labor involved to remove the old and install the new. It’s just not an expense that is worth the money.”

All of these reasons are why you’ll likely only find a large mirror inside near the entrance of the park. And why you’ll likely see an uptick in women carrying compacts.

New York State Stalls Major Cannabis Mergers

New York State’s Department of Health that oversees the medical marijuana program has yet to approve three outstanding proposed acquisitions. The three deals include the MedMen Enterprises Inc. (MMNFF) acquisition of Pharmacann, The Green Thumbs Industries (GTI) acquisition of Fiorello Pharmaceuticals and the Cresco Labs Inc.(CRLBF) deal with Valley Agriceuticals.

It had looked like New York was fast-tracking full legalization this year, but then at the last minute, cannabis funding was not included in the Governor’s budget. It looked like adult use marijuana was pushed off to another year. Then Governor Cuomo said that wasn’t the case and that in fact, negotiations were continuing. As all the back and forth continues, these companies have to wait patiently for the state to figure out its next moves.

RELATED: New York State Only Pretends It Wants Diversity In Cannabis Companies

The Department would only say in response to questions, “The New York State Department of Health is currently reviewing MedMen’s formal merger request with PharmaCann, which they submitted in January. The Department initially denied requests from Valley Agriceuticals/Cresco and Fiorello/GTI. Both have recently resubmitted their requests, which are currently under review.”

A GTI spokesperson said, “The transaction is still in regulatory review and we expect an answer in the near future.” MedMen and Cresco have preferred to stay mum on the situation. Although it seems the Pharmacann acquisition has been approved in all the other states, leaving just New York to green light the deal.

MedMen had announced its deal back on October 11, 2018, and said at that time that the resulting pro-forma company was anticipated to have a portfolio of cannabis licenses across the U.S. that would permit the combined company to operate 76 retail stores and 16 cultivation and production facilities.  MedMen is expected to add licenses in Illinois, New York, Pennsylvania, Maryland, Massachusetts, Ohio, Virginia, and Michigan as a result of the deal.

RELATED: How Gov. Andrew Cuomo Might Legalize Marijuana In New York

Cresco had stated in a filing that on October 24, 2018, it had entered into a definitive agreement to merge a subsidiary with and into Gloucester Street Capital, LLC, the parent entity of Valley Agriceuticals. Valley Ag is one of the ten holders of a vertically integrated license from the New York State Department of Health. To date, the only material asset of Valley Ag is the vertically integrated license from the NYSDOH. Cresco said it had expected the closing to occur in the fourth quarter of 2018 or the first quarter of 2019.

Fiorello Pharmaceuticals, also known as FP Wellness, is licensed in New York state only. It is privately owned. The company lists its partners as The Clinic, Plant Consulting Group and LIU Pharmacy on its website. A report in the Daily Gazette said Fiorello Pharmaceuticals is building a medical marijuana production facility in Glenville and plans to open other dispensaries in Monroe, Nassau and New York counties. Green Thumb Industries or GTI (CSE: GTII) (OTC: (GTBIF) ) has plans to acquire FP Wellness, according to a company spokesperson.

The Buffalo News reported that there are two issues holding up the adult use legislation. The first is that Assembly Majority Leader Crystal Peoples-Stokes, who introduced the Marijuana Regulation and Taxation Act in 2013, “has insisted that half of the tax revenue should go toward reinvesting in communities that have borne the brunt of the war on drugs.” It seems the Governor is on board with this, but the tax revenue is estimated to be $300 million and he has also said he’d like to use some of that money for infrastructure projects like fixing the transit maintenance issues.

The paper said that the other issue was regarding the licenses and how to award them. The original five licensees have not made any profits and then the program was expanded to ten licenses. This group wants first dibs on recreational licenses in order to recoup their investments. The state, however, seems to be eyeing substantial license bidding fees that could potentially cause the only female-owned medical marijuana Etain to go out of business.

The state has been facing criticism that the program is heavily tilted towards corporate cannabis with no diversity except for Etain. This could be why the acquisition approvals have been stalled.

This article originally appeared on Green Market Report.

Lori Loughlin Could Face Up To 40 Years In Jail; Gwen Stefani’s lips, hair criticized

Lori Loughlin could now face up to 40 years in jail after new charges

Actress Lori Loughlin and her fashion designer husband, Mossimo Giannulli, two of the 16 parents indicted on fraud and money laundering charges in the college admissions cheating scandal, could face up to 40 years in prison—a maximum of 20 years for each of the charges, a report said.

The “Fuller House” star and her husband, along with 14 other parents, are being charged with a “second superseding indictment with conspiring to commit fraud and money laundering,” the Department of Justice revealed in a statement to Fox News on Tuesday.

Last month, Loughlin and Giannulli were charged with conspiracy to commit mail fraud. They allegedly paid $500,000 to get their daughters into the University of Southern California as crew recruits, even though the young women did not play the sport.

“The second superseding indictment also charges the defendants with conspiring to launder the bribes and other payments in furtherance of the fraud by funneling them through Singer’s purported charity and his for-profit corporation, as well as by transferring money into the United States, from outside the United States, for the purpose of promoting the fraud scheme,” the statement added.

The two charges the parents now face—conspiracy to commit mail fraud and money laundering—each carries a maximum of 20 years in prison, along with a combined fine of $750,000, according to the New York Daily News

Gwen Stefani’s lips, hair criticized

Some Gwen Stefani fans were shocked by the singer’s look at the Academy of Country Music Awards on Sunday — and not necessarily because of her show-stopping attire.

After Stefani, 49, posted a photo of herself to Instagram from the awards show, some commenters were quick to say the singer didn’t look like herself, specifically referencing her lips, makeup and hair, among other features.

https://www.instagram.com/p/Bv_f0bDFQpC/

“New lips who dis?” one user commented.

“Don’t like the hair,” another said.

“Sorry Gwen, I am not really a fan of this look for once…too much [and] too fake, it doesn’t fit you I think,” wrote another.

Some questioned whether or not the star had cosmetic surgery.

“Chill on the surgery,” one Instagram user commented.

But others came to singer’s defense, writing she looked “gorgeous” at the ACM Awards.

“Very beautiful,” one wrote.

Dogs Can Tell When Their Owners Are Upset And Will Try To Help Them

A new study confirms what we all know: dogs are the best and they have a special bond with their owners, especially when these are feeling sad or distressed.

The study, published in the journal Learning and Behavior, analyzed 34 dogs and their owners, bringing them into a lab for some trials. Scientists separated owners from dogs and put them within eyesight of each other. Owners were told to yell “Help!” every 15 seconds, with either an unaffected or a distressed tone.

The recordings of the tests showed a pattern. Although most dogs were eager to return to their owner whenever they spoke, they tended to run towards them 40 seconds faster when the demand was distressed.

RELATED: This Is Why We Value Dogs More Than Cats

The sample size of the study is small, so conclusive evidence can’t be drawn, but this attentive behavior from dogs is quite common. Data demonstrates that most dogs are very attuned to their owner’s feelings, much more in tune to them than they are to the feelings of fellow dogs, giving them the chance to know when humans are depressed or sick. According to  The Atlantic, dogs have a highly developed sense of smell and hearing, helping them notice changes in your moods and health that you might not even be aware of.

Your tone of voice or tears will attract your dog’s attention and make them more attentive of you. Maybe it’s because they love you unconditionally or because they find your behavior curious and want to understand it. It’s cute either way.

Apple Might Launch 5 iPhones This Year, Some Of Them With 3 Cameras

A new report claims that this year, Apple will launch a grand total of five iPhones. Three of these devices will be upgraded versions of last year’s models, with the other two being new smartphones with three rear cameras and larger lenses.

The report comes from Japanese tech blogger Macotakara who cites sources from Apple’s supply chain in China. It includes a mock up of images showing off the look of the devices, which have a cluttered back with three camera slots with large lenses. Although the mock up suggests some serious camera power, it lacks Apple’s traditionally sleek design.

RELATED: The 6 Most Notable Features Of Apple’s Newest iOS

According to the report, these phones will have a similar width and length to Apple’s current lineup of iPhones, only being a few millimeters thicker and including upgraded chips and features.

While some people find it hard to believe that Apple would release five phones within the span of a single year, other experts point out that Apple is working hard to switch things up. Their current lineup of iPads includes five models with different specs and prices.

We’ll have to wait until this Fall to confirm Apple’s plans, but it’s safe to assume that multiple cameras will be featured. During the past couple of years smartphone makers like Huawei, Samsung and Nokia have included up to five cameras on their devices. It doesn’t make for the most discreet look but the resulting photos are gorgeous.

Tiki Barber Explains How NFL Players Beat Marijuana Drug Tests

If you’ve been watching closely, we’ve been dropping hints about the worst-kept secret in the NFL—a lot of football players consume marijuana. Most teams don’t care all that much if their players use it either, which is why owners have already prepared to concede cannabis regulations ahead of the upcoming Collective Bargaining Agreement with its players.

All this begs the question: If so many players use cannabis now, despite it being against the current rules, how do they all get away it? Luckily, former New York Giants running back Tiki Barber recently shed light on it all in an interview with FOX Business. The drug tests, according to Barber, were extremely easy to beat.

RELATED: 4 Biggest Former Pro Athletes Involved In The Marijuana Business

“We always used to call it like the ‘dummy test’ because you know when the test is going to happen so just be clean and as long as you’re not in the program you can probably get away with it even if they technically know that it’s happening,” Barber told FOX Business.

Barber has a closer insight between cannabis and football than most. The former player has since launched an investment firm that assists marijuana startups navigate the beginning tangles of such a nascent industry. The company is called Grove Group Management, which Barber started with business partner Kevin Shin, and has already begun working with a number of a small businesses.

“It’s simply a business opportunity,” Barber said. “We wanted to put a group together that could attack this cannabis space in an intelligent way that makes sense for not only the business opportunity but also for minority communities and create a message of social progress.”

RELATED: Joe Montana Makes Blockbuster Investment In California Cannabis Company

But Barber, who uses CBD-infused products to manage residual pain from his playing days, believes the NFL needs to change its approach in letting players use marijuana for pain management.

“It’s an evolving conversation with the league and I’m sure come 2020 or 2021 with a new collective bargaining agreement going to be negotiated, it’s going to be a talking point. Guys are tired of managing their pain with things that are going to destroy their livers and make their lives down the line very untenable in some ways,” Barber said.

Thomas Markle Won’t Ever Meet His Grandchild, Says Royal Expert

It’s been a rough patch for Thomas Markle. In less than a year, he bailed on his daughter’s wedding to Prince Harry, he was outed as profiting off her newfound celebrity, and exploiting her “controlling” personality to gain media attention. To put it bluntly, Meghan Markle’s father has made a name for himself by playing the victim.

And now he’s paying the price.

In a preview for the new TLC documentary “Meghan and Harry: A Royal Baby Story”, royal expert Duncan Larcombe, author of “Prince Harry: The Inside Story,” admitted Thomas Markle likely won’t get to ever see his own grandkid.

RELATED: Thomas Markle Is Happy Over Meghan Markle’s Pregnancy

“I can’t think for a moment that Thomas Markle will ever be able to meet his grandson or granddaughter,” says Larcombe, followed by a clip of Meghan’s half-sister, Samantha, claiming that Meghan is now playing the victim after hurting her family.

The one-hour special premieres tonight at at 8 P.M. ET/PT.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.